CLINICAL RESEARCH: AUTONOMIC FUNCTION
Central Sympatholysis as a Novel Countermeasure for Cocaine-Induced Sympathetic Activation and Vasoconstriction in Humans
Dileep V. Menon, MD,
Zhongyun Wang, MD,
Paul J. Fadel, PhD,
Debbie Arbique, RN,
David Leonard, PhD,
Jia-Ling Li, MD,
Ronald G. Victor, MD, FACC1 and
Wanpen Vongpatanasin, MD, FACC1,*
Hypertension Division and the Donald W. Reynolds Cardiovascular Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, Texas.
Manuscript received December 12, 2006;
revised manuscript received March 14, 2007,
accepted March 28, 2007.
* Reprint requests and correspondence: Dr. Wanpen Vongpatanasin, Divisions of Hypertension and Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, J4.134, Dallas, Texas 75390-8586. (Email: wanpen.vongpatanasin{at}utsouthwestern.edu).
Objectives: The aim of this study was to determine whether cocaines sympathomimetic actions can be reversed by a potent centrally acting 2 adrenergic receptor (AR) agonist (dexmedetomidine).
Background: We recently showed that cocaine stimulates the human cardiovascular system primarily by acting in the brain to increase sympathetic nerve activity (SNA), the neural stimulus to norepinephrine release. Thus, SNA constitutes a putative new drug target to block cocaines adverse cardiovascular effects at their origin.
Methods: In 22 healthy cocaine-naïve humans, we measured skin SNA (microneurography) and skin blood flow (laser Doppler velocimetry) as well as heart rate and blood pressure before and after intranasal cocaine (2 mg/kg) alone and in combination with dexmedetomidine or saline.
Results: During intranasal cocaine alone, SNA increased by 2-fold and skin vascular resistance increased from 13.2 ± 2.3 to 20.1 ± 2.2 resistance units while mean arterial pressure increased by 14 ± 3 mm Hg and heart rate by 18 ± 3 beats/min (p < 0.01). Dexmedetomidine abolished these increases, whereas intravenous saline was without effect. Dexmedetomidine was effective in blocking these sympathomimetic actions of cocaine even in all 7 subjects who were homozygous for the Del322-325 polymorphism in the 2C AR, a loss-of-function mutation that is highly enriched in blacks.
Conclusions: The data advance the novel hypothesis that central sympatholysis with dexmedetomidine constitutes a highly effective countermeasure for cocaines sympathomimetic actions on the human cardiovascular system, even in individuals carrying the 2CDel322-325 polymorphism. (Study to Improve Scientific Understanding of the Cardiovascular Actions of Cocaine; http://clinicaltrials.gov/ct/show/NCT00338546?order=1; NCT00338546
[ClinicalTrials.gov]
)
|
Abbreviations and Acronyms
| 2 AR = alpha 2 adrenergic receptor | 2CDel322-325 = deletion 322-325 polymorphism of the alpha 2C AR | | DNA = deoxyribonucleic acid | | MAP = mean arterial pressure | | NE = norepinephrine | | OAAS = observers assessment of alertness/sedation scale | | PCR = polymerase chain reaction | | SNA = sympathetic nerve activity |
|
Related Article
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2007 50: A31-A32.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
J. B. Finkel and G. D. Marhefka
Rethinking Cocaine-Associated Chest Pain and Acute Coronary Syndromes
Mayo Clin. Proc.,
December 1, 2011;
86(12):
1198 - 1207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Schwartz, S. Rezkalla, and R. A. Kloner
Cardiovascular Effects of Cocaine
Circulation,
December 14, 2010;
122(24):
2558 - 2569.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Macmahon and V. R. Tallentire
Stimulating stuff: the pathological effects of cocaine and amphetamines on the cardiovascular system
The British Journal of Diabetes & Vascular Disease,
September 1, 2010;
10(5):
251 - 255.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Singh, A. Khaja, and M. A Alpert
Cocaine and aortic dissection
Vascular Medicine,
April 1, 2010;
15(2):
127 - 133.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. N. Young, J. P. Fisher, K. M. Gallagher, A. Whaley-Connell, K. Chaudhary, R. G. Victor, G. D. Thomas, and P. J. Fadel
Inhibition of nitric oxide synthase evokes central sympatho-excitation in healthy humans
J. Physiol.,
October 15, 2009;
587(20):
4977 - 4986.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|